Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2002 1
2003 1
2004 1
2005 2
2006 1
2008 2
2009 4
2010 2
2011 3
2012 3
2013 2
2014 2
2015 3
2016 4
2017 4
2018 6
2019 6
2020 7
2021 8
2022 9
2023 8
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study.
Rivero-Gallegos D, Mejía M, Rocha-González HI, Huerta-Cruz JC, Falfán-Valencia R, Ramos-Martínez E, Mateos-Toledo HN, Castillo-López MF, Rodríguez-Torres YK, Lira-Boussart V, Rojas-Serrano J. Rivero-Gallegos D, et al. Among authors: rojas serrano j. Clin Rheumatol. 2024 Apr 20. doi: 10.1007/s10067-024-06965-w. Online ahead of print. Clin Rheumatol. 2024. PMID: 38642252
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.
Loganathan A, Zanframundo G, Yoshida A, Faghihi-Kashani S, Bauer Ventura I, Dourado E, Bozan F, Sambataro G, Yamano Y, Bae SS, Lim D, Ceribelli A, Isailovic N, Selmi C, Fertig N, Bravi E, Kaneko Y, Saraiva AP, Jovani V, Bachiller-Corral J, Cifrian J, Mera-Varela A, Moghadam-Kia S, Wolff V, Campagne J, Meyer A, Giannini M, Triantafyllias K, Knitza J, Gupta L, Molad Y, Iannone F, Cavazzana I, Piga M, De Luca G, Tansley S, Bozzalla-Cassione E, Bonella F, Corte TJ, Doyle TJ, Fiorentino D, Gonzalez-Gay MA, Hudson M, Kuwana M, Lundberg IE, Mammen AL, McHugh NJ, Miller FW, Montecucco C, Oddis CV, Rojas-Serrano J, Schmidt J, Scirè CA, Selva-O'Callaghan A, Werth VP, Alpini C, Bozzini S, Cavagna L, Aggarwal R; CLASS Project. Loganathan A, et al. Among authors: rojas serrano j. Clin Exp Rheumatol. 2024 Feb;42(2):277-287. doi: 10.55563/clinexprheumatol/s14zq8. Epub 2024 Mar 14. Clin Exp Rheumatol. 2024. PMID: 38488094 Free article.
Characteristics and risk factors of COVID-19 breakthrough infections in Idiopathic Inflammatory Myopathies: Results from the COVAD study.
Hoff LS, Naveen R, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK, Ziade N, Velikova T, Milchert M, Jagtap K, Parodis I, Edgar Gracia-Ramos A, Cavagna L, Kuwana M, Knitza J, Chen YM, Makol A, Agarwal V, Patel A, Pauling JD, Wincup C, Barman B, Zamora Tehozol EA, Rojas Serrano J, García-De La Torre I, Colunga-Pedraza IJ, Merayo-Chalico J, Chibuzo OC, Katchamart W, Akarawatcharangura Goo P, Shumnalieva R, El Kibbi L, Halabi H, Vaidya B, Shaharir SS, Hasan ATMT, Dey D, Toro Gutiérrez CE, Caballero-Uribe CV, Lilleker JB, Salim B, Gheita T, Chatterjee T, Distler O, Saavedra MA; COVAD study group; Chinoy H, Agarwal V, Aggarwal R, Gupta L. Hoff LS, et al. Among authors: rojas serrano j. Rheumatology (Oxford). 2024 Mar 2:keae128. doi: 10.1093/rheumatology/keae128. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38430474
The type 2 inflammatory response favors recognition of tumor antigens by IgE in breast cancer.
Ramos-Martinez E, García-Vazquez FJ, Falfán-Valencia R, Rojas-Serrano J, Alfaro-Cruz A, Pérez-Villaseñor M, Aristi-Urista G, Pérez-Hernández J, López-Vancell R, Velasco-Medina A, Velázquez-Sámano G. Ramos-Martinez E, et al. Among authors: rojas serrano j. Cancer Rep (Hoboken). 2024 Feb;7(2):e2002. doi: 10.1002/cnr2.2002. Cancer Rep (Hoboken). 2024. PMID: 38389406 Free PMC article.
Pulmonary manifestations and prognosis of a cohort of patients with interstitial lung disease and positive to anti-Th/To autoantibodies.
Mejía M, Ramos-Martínez E, Vázquez-Becerra LE, Fernández-Badillo D, Mateos-Toledo HN, Castillo J, Estrada A, Rojas-Serrano J. Mejía M, et al. Among authors: rojas serrano j. Med Clin (Barc). 2024 Apr 26;162(8):378-384. doi: 10.1016/j.medcli.2023.11.023. Epub 2024 Jan 29. Med Clin (Barc). 2024. PMID: 38290874 English, Spanish.
Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease.
Quintero-Puerta T, Lira-Lucio JA, Falfán-Valencia R, Vega-Sánchez ÁE, Márquez-García E, Mejía M, Bautista-Becerril B, Rojas-Serrano J, Ramos-Martínez E, Buendía-Roldán I, Pérez-Rubio G. Quintero-Puerta T, et al. Among authors: rojas serrano j. Front Cell Infect Microbiol. 2023 Dec 5;13:1321315. doi: 10.3389/fcimb.2023.1321315. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38116136 Free PMC article.
Molecular Factors in PAD2 (PADI2) and PAD4 (PADI4) Are Associated with Interstitial Lung Disease Susceptibility in Rheumatoid Arthritis Patients.
Nava-Quiroz KJ, Rojas-Serrano J, Pérez-Rubio G, Buendia-Roldan I, Mejía M, Fernández-López JC, Rodríguez-Henríquez P, Ayala-Alcantar N, Ramos-Martínez E, López-Flores LA, Del Ángel-Pablo AD, Falfán-Valencia R. Nava-Quiroz KJ, et al. Among authors: rojas serrano j. Cells. 2023 Sep 8;12(18):2235. doi: 10.3390/cells12182235. Cells. 2023. PMID: 37759458 Free PMC article.
Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials.
Hong H, Friedland A, Hu M, Anstrom KJ, Halabi S, McKinnon JE, Amaravadi R, Rojas-Serrano J, Abella BS, Portillo-Vázquez AM, Woods CW, Hernandez AF, Boulware DR, Naggie S, Rajasingham R. Hong H, et al. Among authors: rojas serrano j. BMJ Open. 2023 Jun 16;13(6):e065305. doi: 10.1136/bmjopen-2022-065305. BMJ Open. 2023. PMID: 37328184 Free PMC article.
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
R N, Sen P, Griger Z, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK, Ziade N, Velikova T, Milchert M, Jagtap K, Parodis I, Gracia-Ramos AE, Cavagna L, Kuwana M, Knitza J, Chen YM, Makol A, Agarwal V, Patel A, Pauling JD, Wincup C, Barman B, Zamora Tehozol EA, Rojas Serrano J, García-De La Torre I, Colunga-Pedraza IJ, Merayo-Chalico J, Chibuzo OC, Katchamart W, Akarawatcharangura Goo P, Shumnalieva R, Hoff LS, El Kibbi L, Halabi H, Vaidya B, Shaharir SS, Hasan ATMT, Dey D, Toro Gutiérrez CE, Caballero-Uribe CV, Lilleker JB, Salim B, Gheita T, Chatterjee T, Distler O, Saavedra MA, Chinoy H, Agarwal V, Aggarwal R, Gupta L; COVAD Study Group. R N, et al. Among authors: rojas serrano j. Rheumatology (Oxford). 2024 Jan 4;63(1):127-139. doi: 10.1093/rheumatology/kead180. Rheumatology (Oxford). 2024. PMID: 37084267
77 results